Published: July 30, 2012
Private equity firm to buy 50% of Turkish pharmaceutical company.
Private equity firm Mid Europa Partners has agreed to buy 50% of Walmark, a Turkish pharmacutical company.
The shareholding is to be acquired from the company’s founders for an undisclosed sum. The deal is expected to close in the final quarter of the year.
Michelle Capiod, the director leading the deal for Mid Europa, said acquisitions will be part of the firm's strategy to strengthen Walmark’s market position and product offering.
This is Mid Europa’s first acquisition in Turkey since it bought 65% of private healthcare operator Kent Hospital Group in October.
Walmark generates almost €100mn (US$122.4mn) making vitamins, minerals and dietary supplements for sale in central and eastern Europe.